Henry Schein

Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution, and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, laboratory, small and large equipment repair services, branded and generic pharmaceuticals, vaccines, surgicals, diagnostic tests, infection-control products and vitamins. The Technology & Value-Added Services segment offers financial on a non-recourse basis, network and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Henry Schein reports solid Q4 performance and anticipates growth

Henry Schein's Q4 performance showcased growth amidst challenges, with a strategic focus on core margin expansion and strong performance in dental specialties. While facing challenges from declining PPE sales and supply chain issues, the company sees opportunities in stable dental markets and continued growth in operating income. Overall, the company remains optimistic about its outlook for 2023.

Henry Schein reports strong Q1 earnings, eyes growth through acquisitions

Henry Schein's Q1 2023 earnings call highlighted strong financial performance across its dental, medical, and Technology and Value-Added Services businesses. While facing challenges from declining PPE and COVID-19 test kit sales, the company remains optimistic about growth opportunities through acquisitions and stable business segments.

Henry Schein reports solid Q2 results, eyes growth opportunities

Henry Schein's Q2 performance was driven by strong dental sales, while facing challenges from declining PPE and COVID test kit sales. The company is focused on strategic acquisitions and expanding product offerings, with opportunities in technology and specialty products driving growth.

Henry Schein navigates post-cyber incident challenges, focuses on recovery

Henry Schein faced challenges from a cybersecurity incident impacting operations but showcased resilience and recovery efforts across its business segments.
Strategic initiatives focused on customer retention, operational efficiency, and cybersecurity response highlight the company's commitment to long-term growth and stability.
Despite challenges in specific segments and cybersecurity spending variables, Henry Schein's focus on recovery, cost-cutting, and customer trust positions it for future opportunities.
The company's emphasis on digital channels, stable medical demand, and strategic cost-cutting measures underscores its adaptability and strategic vision for sustained growth.

Henry Schein reports resilient Q4 performance and outlines 2024 guidance

Henry Schein's Q4 2023 performance reflects resilience amidst challenges, with a strategic focus on technology, global sales, and recovery post-cyber incident. The company's 2024 outlook includes managing residual cyber impacts and pursuing growth opportunities.

Henry Schein reports solid Q1 earnings, eyes market share expansion

Henry Schein's Q1 performance reflects resilience and growth across key segments, with a focus on market share expansion and profitability. While facing challenges in dental consumables and pricing stability, the company is leveraging opportunities in product portfolio expansion and market positioning. Strategic acquisitions and recovery efforts post-cyber incident are driving competitive strength and customer loyalty.

Henry Schein reports mixed Q2 performance, focuses on cost savings

Henry Schein navigated challenges from a cyber incident, with mixed performance across segments in Q2 2024.
Strong sales growth in dental specialties, focus on cost savings, and resilience in technology services were highlights.
The company's strategic initiatives, financial guidance update, and confidence in future prospects were key takeaways from the call.

Henry Schein excels in Q3 with strategic growth initiatives

Henry Schein's Q3 performance reflects strong market positioning and strategic execution, driving growth across key business segments.
While facing challenges such as LCI sales decline, the company's focus on operational efficiency and cost management remains a priority.
With increased sales guidance, ongoing restructuring initiatives, and strategic capital allocation plans, Henry Schein is poised for continued success and expansion.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, laboratory, small and large equipment repair services, branded and generic pharmaceuticals, vaccines, surgical, diagnostic tests, infection-control products, and vitamins. The Technology and Value-Added Services segment offers financial on a non-recourse basis, network, and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.

Henry Schein inked a new agreement to acquire Acentus to enhance its ability to deliver CGM products directly to patients' homes.

HSIC Stock Likely to Gain From Its Latest Acquisition of Acentus

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein to participate in investor conferences in December.

Henry Schein to Participate in Investor Conferences in December

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein to acquire Acentus, a leading supplier of homecare medical products.

Henry Schein to Acquire Acentus, a Leading Supplier of Homecare Medical Products

Activist investor Ananym Capital Management is urging healthcare products distributor Henry Schein to refresh its board, cut costs, tackle succession planning and consider selling its medical distribution business, sources close to matter said on Monday.

Exclusive: Activist investor Ananym Capital pushes for changes at Henry Schein, sources say

Henry Schein shares climbed more than 4% in Monday trading, on track to notch their best day since July. Financial firm Gordon Haskett said Robert F.

Dental supply stock rallies on theory RFK's anti-fluoride stance will prompt more dentist visits

Henry Schein, Inc. (NASDAQ:HSIC ) Q3 2024 Earnings Conference Call November 5, 2024 10:00 AM ET Company Participants Graham Stanley - VP, IR & Strategic Financial Project Officer Stanley Bergman - Chairman & CEO Ronald South - SVP and CFO Conference Call Participants Elizabeth Anderson - Evercore ISI Jeffrey Johnson - Baird Kevin Caliendo - UBS Jonathan Block - Stifel Jason Bednar - Piper Sandler John Stansel - JPMorgan Brandon Vazquez - William Blair Michael Petusky - Barrington Research Operator Good morning, ladies and gentlemen, and welcome to Henry Schein's Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.

Henry Schein, Inc. (HSIC) Q3 2024 Earnings Call Transcript

The headline numbers for Henry Schein (HSIC) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Henry Schein (HSIC) Reports Q3 Earnings: What Key Metrics Have to Say

Henry Schein's third-quarter results reflect an improvement in sales trends in Technology and Value-Added Services business.

HSIC Q3 Earnings Top, Margins Down, Stock Gains in Premarket

Henry Schein (HSIC) came out with quarterly earnings of $1.22 per share, beating the Zacks Consensus Estimate of $1.16 per share. This compares to earnings of $1.32 per share a year ago.

Henry Schein (HSIC) Q3 Earnings Top Estimates

Dental products distributor Henry Schein beat third-quarter profit estimates on Tuesday, as a series of cost-saving measures helped counter tepid demand and slow recovery from a cyberattack it disclosed in October last year.

Henry Schein beats quarterly profit estimates on lower costs

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein reports third quarter 2024 financial results and increases 2024 financial guidance.

Henry Schein Reports Third Quarter 2024 Financial Results and Increases 2024 Financial Guidance

Get a deeper insight into the potential performance of Henry Schein (HSIC) for the quarter ended September 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Unlocking Q3 Potential of Henry Schein (HSIC): Exploring Wall Street Estimates for Key Metrics

Henry Schein (HSIC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Henry Schein (HSIC) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

OKLAHOMA CITY--(BUSINESS WIRE)-- #FedermanSherwood--Federman & Sherwood Investigates Henry Schein, Inc. for Data Breach.

Federman & Sherwood Investigates Henry Schein, Inc. for Data Breach

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein to participate in investor conferences in November.

Henry Schein to Participate in Investor Conferences in November

Henry Schein is expected to report impressive sales in both its businesses in the third quarter of 2024, along with a low pace of recovery from the cyber incident.

HSIC Gears Up for Q3 Earnings: Here's What You Need to Know

Henry Schein (HSIC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Why Henry Schein (HSIC) Could Beat Earnings Estimates Again

Henry Schein strategically sets up distribution centers worldwide to better serve customers and increase its operating efficiency.

Henry Schein Stock Gains From Dental Business Expansion Amid Macro Woe

Zentek Ltd

GUELPH, ON / ACCESSWIRE / October 17, 2024 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, is pleased to provide an update on recent commercialization activities for its ZenGUARD™Antimicrobial Surgical Masks.

Zentek Provides Market Update on ZenGUARD(TM) Antimicrobial Surgical Masks

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) reminds its customers in Florida and all areas in the projected path of Hurricane Milton that the Henry Schein Customer Assistance Hotline is open for dental and medical professionals who may experience operational, logistical, or financial issues as a result of damage caused by the hurricane. The toll-free number for all Henry Schein customers is 800-999-9729. The hotline is open 24/7, with real-time assistance available from T.

Henry Schein Opens Customer Assistance Hotline Ahead of Hurricane Milton

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) today announced the opening of the Henry Schein Cares Foundation 2024 Relief Fund to support the Southeast U.S. Contributions will help ensure critical supplies and resources can help people impacted by Hurricane Helene. The Company and Henry Schein Cares Foundation will donate an initial $25,000 each to support relief efforts and the Company will match TSM contributions up to another $50,000, for a cash total of up to $150,000.

Henry Schein Opens Henry Schein Cares Foundation 2024 Relief Fund and Commits Up to $500,000 in Cash and Essential Health Care Supplies to Support the Southeast U.S.

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) today announced the annual launch of its 2024 Practice Pink® program, a global initiative that has donated more than $2 million over the past 18 years to help create awareness and support for the campaign against cancer. The program is an initiative of Henry Schein Cares, the Company's global corporate citizenship program. Through the Practice Pink program, Henry Schein, together with non-governmental organizations and supplier.

Supporting Cancer Patients: Henry Schein's Practice Pink Program Raises $2 Million Over 18 Years

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that it will release its third quarter 2024 financial results before the stock market opens on Tuesday, November 5, 2024, and will provide a live webcast of its earnings conference call on the same day beginning at 10:00 a.m. Eastern time. Speakers on the call will include Stanley M. Bergman, Chairman of the B.

Henry Schein to Webcast Third Quarter 2024 Conference Call on Tuesday, November 5, 2024 at 10:00 a.m. ET

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) today announced that more than 2,300 Team Schein Members (TSMs) from around the world have joined together to build nearly 23,000 hygiene kits for families with children facing serious medical illnesses. TSMs built the kits as part of the Company's fourth “We Care Global Challenge,” an initiative that aims to bring colleagues together under the shared mission of “helping health happen” for people and communities in need. Intende.

Henry Schein Builds Nearly 23,000 Hygiene Kits for Families Staying at Ronald McDonald House Charities Around the World

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) reminds its customers in Florida and all areas in the projected path of Hurricane Helene that the Henry Schein Customer Assistance Hotline is open for dentists and physicians who may experience operational, logistical, or financial issues as a result of damage caused by the hurricane. The toll-free number for all Henry Schein customers is 800-999-9729. The hotline is open 24/7, with real-time assistance available from Team Schei.

News for Henry Schein Stock (HSIC)